Health Care

KIMS Hospitals Posts Strong Revenue Growth in Q3 FY26, Profitability Impacted by Financing Costs and Expansion Investments

● Feb 8, 2026

Krishna Institute of Medical Sciences Ltd (NSE:KIMS), a leading multi-specialty hospital chains, reported strong revenue growth in the third quarter...

Sai Life Sciences Reports Strong Q3 FY26 Growth with 27% Revenue Rise

● Feb 6, 2026

Sai Life Sciences Limited (BSE: 544306, NSE: SAILIFE), a leading Indian Contract Research, Development and Manufacturing Organization (CRDMO), announced its...

Suraksha Diagnostic Ltd Total Income grew by 30.3% year-on-year in Q3 FY26

● Feb 6, 2026

About Suraksha Diagnostic Ltd. Suraksha Diagnostic Ltd. (NSE: SURAKSHA) is an Indian healthcare company that operates a wide network of...

Krsnaa Diagnostics Q3 FY26 Earnings Results

● Feb 6, 2026

Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals,...

Sequent Scientific (Viyash) reports higher revenue and margins in first merged-entity quarter

● Feb 5, 2026

Sequent Scientific Limited (now Viyash Scientific Limited) (BSE: 512529 / NSE: SEQUENT) reported higher revenue and profitability in the quarter...

Inventurus Knowledge Solutions Reports 24% Revenue Growth in Q3 FY26

● Feb 5, 2026

Technology-enabled healthcare provider sees PAT surge 41% amid increased US outsourcing demand. Integrated platform adoption drives margin expansion to 35%...

Metropolis Healthcare Reports 26% Revenue Growth in Q3; Board Approves 3:1 Bonus Issue

● Feb 5, 2026

India’s second-largest diagnostic chain saw net profit surge 63% on an adjusted basis as specialty testing and acquisition integrations drove...

Metropolis Healthcare posts higher revenue and margins in Q3 FY26 on volume growth and mix improvement

● Feb 4, 2026

Metropolis Healthcare Limited (BSE: 542650 / NSE: METROPOLIS) reported higher revenue and profitability in the quarter ended December 31, 2025,...

Rubicon Research Reports 52% Revenue Growth in Q3 FY26; Profit Nearly Doubles

● Feb 3, 2026

Rubicon Research Limited (NSE: RUBICON) shares were trading higher following the release of its Q3 FY26 earnings, though stock price...

Indoco Remedies Q3 Revenue Slips as Losses Widen Despite Operating Recovery

● Feb 3, 2026

Indoco Remedies Limited (NSE:INDOCO) closed at ₹235.00 on February 3, 2026, up 10.88% from the previous close of ₹211.94, surging...